Page last updated: 2024-08-23

selegiline and oxybutynin

selegiline has been researched along with oxybutynin in 9 studies

Research

Studies (9)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (22.22)	29.6817
2010's	7 (77.78)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bleich, S; Gulbins, E; Kornhuber, J; Reichel, M; Terfloth, L; Tripal, P; Wiltfang, J	1
Lombardo, F; Obach, RS; Waters, NJ	1
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Bailey, SR; Bryson, SW; Killen, JD	1
Azzaro, AJ; DelBello, MP; Emslie, G; Hochadel, TJ; Katic, A; Khan, A; Portland, KB	1
Byerly, MJ; Emslie, GJ; Mayes, TL; Nakonezny, PA	1
Bied, AM; Kim, J; Schwartz, TL	1
Cristancho, MA; Thase, ME	1

Reviews

3 review(s) available for selegiline and oxybutynin

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
A critical appraisal of the selegiline transdermal system for major depressive disorder. Expert review of clinical pharmacology, 2015, Volume: 8, Issue:6 Topics: Administration, Cutaneous; Antidepressive Agents; Depressive Disorder, Major; Drug Liberation; Humans; Hypertension; Medication Adherence; Selegiline; Transdermal Patch	2015
Critical appraisal of selegiline transdermal system for major depressive disorder. Expert opinion on drug delivery, 2016, Volume: 13, Issue:5 Topics: Administration, Cutaneous; Depressive Disorder, Major; Humans; Monoamine Oxidase Inhibitors; Selegiline; Skin Absorption; Transdermal Patch	2016

Trials

2 trial(s) available for selegiline and oxybutynin

Article	Year
Predicting successful 24-hr quit attempt in a smoking cessation intervention. Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2011, Volume: 13, Issue:11 Topics: Adult; Behavior Therapy; Double-Blind Method; Female; Follow-Up Studies; Health Promotion; Humans; Logistic Models; Male; Middle Aged; Monoamine Oxidase Inhibitors; Selegiline; Self Report; Sex Factors; Smoking Cessation; Smoking Prevention; Time Factors; Tobacco Use Disorder; Transdermal Patch; Treatment Outcome	2011
A double-blind, placebo-controlled study of selegiline transdermal system in depressed adolescents. Journal of child and adolescent psychopharmacology, 2014, Volume: 24, Issue:6 Topics: Administration, Cutaneous; Adolescent; Antidepressive Agents; Child; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Male; Selegiline; Severity of Illness Index; Transdermal Patch; Treatment Outcome	2014

Article

Year

Predicting successful 24-hr quit attempt in a smoking cessation intervention.

Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2011, Volume: 13, Issue:11

Topics: Adult; Behavior Therapy; Double-Blind Method; Female; Follow-Up Studies; Health Promotion; Humans; Logistic Models; Male; Middle Aged; Monoamine Oxidase Inhibitors; Selegiline; Self Report; Sex Factors; Smoking Cessation; Smoking Prevention; Time Factors; Tobacco Use Disorder; Transdermal Patch; Treatment Outcome

2011

A double-blind, placebo-controlled study of selegiline transdermal system in depressed adolescents.

Journal of child and adolescent psychopharmacology, 2014, Volume: 24, Issue:6

Topics: Administration, Cutaneous; Adolescent; Antidepressive Agents; Child; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Male; Selegiline; Severity of Illness Index; Transdermal Patch; Treatment Outcome

2014

Other Studies

4 other study(ies) available for selegiline and oxybutynin

Article	Year
Identification of new functional inhibitors of acid sphingomyelinase using a structure-property-activity relation model. Journal of medicinal chemistry, 2008, Jan-24, Volume: 51, Issue:2 Topics: Algorithms; Animals; Cell Line; Cell Line, Tumor; Chemical Phenomena; Chemistry, Physical; Enzyme Inhibitors; Humans; Hydrogen-Ion Concentration; Molecular Conformation; Quantitative Structure-Activity Relationship; Rats; Sphingomyelin Phosphodiesterase	2008
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds. Chemical research in toxicology, 2012, Oct-15, Volume: 25, Issue:10 Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding	2012
Predicting placebo response in adolescents with major depressive disorder: The Adolescent Placebo Impact Composite Score (APICS). Journal of psychiatric research, 2015, Volume: 68 Topics: Adolescent; Child; Depressive Disorder, Major; Female; Humans; Male; Models, Statistical; Neuroprotective Agents; Outcome Assessment, Health Care; Placebo Effect; Probability; Randomized Controlled Trials as Topic; Selegiline; Sensitivity and Specificity; Transdermal Patch	2015